Literature DB >> 22090971

5-(Pyridin-4-ylmeth-yl)-1H-pyrazolo-[3,4-d]pyrimidin-4(5H)-one.

Abdulsalam Alsubari, Youssef Ramli, El Mokhtar Essassi, Hafid Zouihri.   

Abstract

In the title compound, C(11)H(9)N(5)O, the pyrazolo-pyrimidin-4-one ring system is almost planar, with a maximum deviation of 0.0546 (13) Å for the O atom. The crystal packing is stabilized by inter-molecular N-H⋯N, C-H⋯O and C-H⋯N hydrogen bonds. In addition, π-π stacking is found between the pyridine ring and the pyrazolo-pyrimidin-4-one ring systems, with centroid-centroid distances in the range 3.9627 (12)-4.6781 (12) Å.

Entities:  

Year:  2011        PMID: 22090971      PMCID: PMC3212314          DOI: 10.1107/S1600536811025025

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For a related structure, see: Al Subari et al. (2010 ▶). For the biological activity of pyrazolo­pyrimidinone derivatives, see: Kim et al. (2001 ▶); Ali et al. (2009 ▶).

Experimental

Crystal data

C11H9N5O M = 227.23 Monoclinic, a = 4.6371 (3) Å b = 19.2731 (10) Å c = 5.8593 (3) Å β = 102.498 (2)° V = 511.24 (5) Å3 Z = 2 Mo Kα radiation μ = 0.10 mm−1 T = 296 K 0.25 × 0.22 × 0.17 mm

Data collection

Bruker APEXII CCD detector diffractometer 6285 measured reflections 2603 independent reflections 2201 reflections with I > 2σ(I) R int = 0.030

Refinement

R[F 2 > 2σ(F 2)] = 0.036 wR(F 2) = 0.085 S = 1.05 2603 reflections 158 parameters 2 restraints H atoms treated by a mixture of independent and constrained refinement Δρmax = 0.16 e Å−3 Δρmin = −0.22 e Å−3 Data collection: APEX2 (Bruker, 2005 ▶); cell refinement: SAINT (Bruker, 2005 ▶); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: PLATON (Spek, 2009 ▶); software used to prepare material for publication: publCIF (Westrip, 2010 ▶). Crystal structure: contains datablock(s) I, global. DOI: 10.1107/S1600536811025025/fj2436sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S1600536811025025/fj2436Isup2.hkl Supplementary material file. DOI: 10.1107/S1600536811025025/fj2436Isup3.cml Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C11H9N5OF(000) = 236
Mr = 227.23Dx = 1.476 Mg m3
Monoclinic, P21Mo Kα radiation, λ = 0.71073 Å
Hall symbol: P 2ybCell parameters from 342 reflections
a = 4.6371 (3) Åθ = 2.4–25.6°
b = 19.2731 (10) ŵ = 0.10 mm1
c = 5.8593 (3) ÅT = 296 K
β = 102.498 (2)°Prism, colourless
V = 511.24 (5) Å30.25 × 0.22 × 0.17 mm
Z = 2
Bruker APEXII CCD detector diffractometer2201 reflections with I > 2σ(I)
Radiation source: fine-focus sealed tubeRint = 0.030
graphiteθmax = 28.9°, θmin = 2.1°
ω and φ scansh = −6→6
6285 measured reflectionsk = −26→26
2603 independent reflectionsl = −7→7
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.036Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.085H atoms treated by a mixture of independent and constrained refinement
S = 1.05w = 1/[σ2(Fo2) + (0.0427P)2 + 0.0014P] where P = (Fo2 + 2Fc2)/3
2603 reflections(Δ/σ)max = 0.001
158 parametersΔρmax = 0.16 e Å3
2 restraintsΔρmin = −0.22 e Å3
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
N20.7680 (3)1.03978 (7)0.5859 (2)0.0280 (3)
N10.3899 (3)0.95388 (6)0.5329 (2)0.0242 (3)
N30.7129 (3)1.11511 (7)0.2529 (2)0.0275 (3)
N50.8324 (3)0.71619 (7)0.6387 (3)0.0326 (3)
N40.5292 (3)1.12382 (7)0.0394 (2)0.0312 (3)
O10.0403 (3)0.93783 (6)0.1944 (2)0.0343 (3)
C80.3807 (3)1.03227 (8)0.2246 (3)0.0233 (3)
C110.6365 (3)0.98760 (8)0.6577 (3)0.0257 (3)
H110.71550.97130.80750.031*
C100.6293 (3)1.06125 (8)0.3675 (3)0.0235 (3)
C70.2488 (4)0.97246 (8)0.3022 (3)0.0242 (3)
C10.4678 (3)0.83113 (8)0.6455 (3)0.0250 (3)
C60.2764 (4)0.89454 (8)0.6453 (3)0.0289 (4)
H6A0.07640.88420.56260.035*
H6B0.27080.90660.80500.035*
C20.6726 (4)0.81124 (9)0.8437 (3)0.0298 (4)
H20.69260.83600.98250.036*
C50.4487 (4)0.79196 (8)0.4448 (3)0.0322 (4)
H50.31300.80360.30870.039*
C40.6333 (4)0.73540 (8)0.4486 (3)0.0351 (4)
H40.61810.70950.31250.042*
C90.3281 (4)1.07419 (8)0.0210 (3)0.0286 (3)
H90.17351.0677−0.10780.034*
C30.8469 (4)0.75365 (9)0.8304 (3)0.0332 (4)
H30.98270.74040.96460.040*
H3N0.869 (4)1.1429 (12)0.304 (4)0.060 (7)*
U11U22U33U12U13U23
N20.0245 (7)0.0290 (7)0.0283 (7)0.0012 (6)0.0011 (6)−0.0026 (6)
N10.0251 (6)0.0209 (6)0.0264 (7)0.0009 (5)0.0052 (5)0.0002 (5)
N30.0274 (7)0.0252 (7)0.0290 (8)−0.0025 (6)0.0042 (6)−0.0006 (6)
N50.0329 (8)0.0251 (7)0.0411 (9)0.0029 (6)0.0108 (7)0.0017 (6)
N40.0343 (8)0.0293 (7)0.0288 (8)0.0020 (6)0.0045 (6)0.0010 (6)
O10.0323 (6)0.0308 (6)0.0355 (7)−0.0077 (5)−0.0025 (5)−0.0025 (5)
C80.0213 (7)0.0222 (7)0.0252 (8)0.0027 (6)0.0020 (6)−0.0028 (6)
C110.0259 (8)0.0267 (8)0.0222 (8)0.0053 (6)0.0003 (6)−0.0015 (6)
C100.0227 (7)0.0215 (7)0.0263 (8)0.0017 (6)0.0050 (6)−0.0034 (6)
C70.0225 (7)0.0223 (7)0.0268 (8)0.0032 (6)0.0032 (6)−0.0039 (6)
C10.0264 (8)0.0221 (7)0.0280 (8)−0.0036 (6)0.0096 (7)0.0014 (6)
C60.0298 (9)0.0261 (8)0.0334 (10)0.0017 (7)0.0130 (8)0.0010 (6)
C20.0357 (9)0.0269 (8)0.0256 (8)−0.0006 (7)0.0041 (7)0.0001 (6)
C50.0360 (10)0.0319 (9)0.0264 (9)0.0023 (7)0.0019 (7)−0.0006 (7)
C40.0448 (11)0.0282 (9)0.0337 (10)0.0017 (8)0.0114 (9)−0.0033 (7)
C90.0296 (8)0.0289 (8)0.0252 (8)0.0009 (7)0.0015 (7)−0.0023 (6)
C30.0317 (9)0.0289 (8)0.0360 (11)−0.0002 (7)0.0006 (8)0.0058 (7)
N2—C111.293 (2)C8—C71.425 (2)
N2—C101.366 (2)C11—H110.9300
N1—C111.379 (2)C1—C51.384 (2)
N1—C71.415 (2)C1—C21.386 (2)
N1—C61.4725 (19)C1—C61.510 (2)
N3—C101.339 (2)C6—H6A0.9700
N3—N41.363 (2)C6—H6B0.9700
N3—H3N0.897 (16)C2—C31.385 (3)
N5—C31.325 (2)C2—H20.9300
N5—C41.336 (2)C5—C41.383 (2)
N4—C91.324 (2)C5—H50.9300
O1—C71.231 (2)C4—H40.9300
C8—C101.387 (2)C9—H90.9300
C8—C91.418 (2)C3—H30.9300
C11—N2—C10112.37 (14)C2—C1—C6121.35 (15)
C11—N1—C7123.10 (13)N1—C6—C1111.23 (11)
C11—N1—C6117.67 (14)N1—C6—H6A109.4
C7—N1—C6119.20 (13)C1—C6—H6A109.4
C10—N3—N4111.39 (14)N1—C6—H6B109.4
C10—N3—H3N126.6 (15)C1—C6—H6B109.4
N4—N3—H3N122.0 (15)H6A—C6—H6B108.0
C3—N5—C4117.08 (15)C3—C2—C1118.49 (16)
C9—N4—N3105.96 (13)C3—C2—H2120.8
C10—C8—C9104.34 (14)C1—C2—H2120.8
C10—C8—C7119.42 (14)C4—C5—C1119.39 (16)
C9—C8—C7136.22 (15)C4—C5—H5120.3
N2—C11—N1126.12 (15)C1—C5—H5120.3
N2—C11—H11116.9N5—C4—C5123.05 (16)
N1—C11—H11116.9N5—C4—H4118.5
N3—C10—N2125.17 (14)C5—C4—H4118.5
N3—C10—C8107.61 (13)N4—C9—C8110.70 (15)
N2—C10—C8127.23 (14)N4—C9—H9124.7
O1—C7—N1120.18 (14)C8—C9—H9124.7
O1—C7—C8128.22 (16)N5—C3—C2124.12 (17)
N1—C7—C8111.59 (14)N5—C3—H3117.9
C5—C1—C2117.87 (15)C2—C3—H3117.9
C5—C1—C6120.77 (15)
D—H···AD—HH···AD···AD—H···A
N3—H3N···N5i0.90 (2)1.96 (2)2.840 (2)168 (2)
C4—H4···N4ii0.932.613.526 (2)167
C9—H9···N2iii0.932.363.289 (2)174
C11—H11···O1iv0.932.523.430 (2)167
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯AD—HH⋯ADAD—H⋯A
N3—H3N⋯N5i0.90 (2)1.96 (2)2.840 (2)168 (2)
C4—H4⋯N4ii0.932.613.526 (2)167
C9—H9⋯N2iii0.932.363.289 (2)174
C11—H11⋯O1iv0.932.523.430 (2)167

Symmetry codes: (i) ; (ii) ; (iii) ; (iv) .

  5 in total

1.  Synthesis and phosphodiesterase 5 inhibitory activity of new 5-phenyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one derivatives containing an N-acylamido group phenyl ring.

Authors:  D K Kim; D H Ryu; N Lee; J Y Lee; J S Kim; S Lee; J Y Choi; J H Ryu; N H Kim; G J Im; W S Choi; T K Kim
Journal:  Bioorg Med Chem       Date:  2001-07       Impact factor: 3.641

2.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

3.  3-[2-(2,3-Dioxoindolin-1-yl)eth-yl]-1,3-oxazolidin-2-one.

Authors:  Abdusalam Al Subari; Rachid Bouhfid; Hafid Zouihri; El Mokhtar Essassi; Seik Weng Ng
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-01-27

4.  Synthesis of some novel pyrazolo[3,4-b]pyridine and pyrazolo[3,4-d]pyrimidine derivatives bearing 5,6-diphenyl-1,2,4-triazine moiety as potential antimicrobial agents.

Authors:  Tarik El-Sayed Ali
Journal:  Eur J Med Chem       Date:  2009-06-12       Impact factor: 6.514

5.  Structure validation in chemical crystallography.

Authors:  Anthony L Spek
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-01-20
  5 in total
  4 in total

1.  4-Benzyl-sulfanyl-1H-pyrazolo-[3,4-d]pyrimidine.

Authors:  Mohammed El Fal; Youssef Ramli; El Mokhtar Essassi; Mohamed Saadi; Lahcen El Ammari
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-10-16

2.  The crystal structure of 1,5-dibenzyl-1H-pyrazolo-[3,4-d]pyrimidine-4(5H)-thione.

Authors:  Mohammed El Fal; Youssef Ramli; El Mokhtar Essassi; Mohamed Saadi; Lahcen El Ammari
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-01-10

3.  Crystal structure of 4-allyl-sulfanyl-1H-pyrazolo-[3,4-d]pyrimidine.

Authors:  Mohammed El Fal; Youssef Ramli; El Mokhtar Essassi; Mohamed Saadi; Lahcen El Ammari
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2014-08-23

4.  Crystal structure of 1-ethyl-pyrazolo[3,4-d]pyrimidine-4(5H)-thione.

Authors:  Mohammed El Fal; Youssef Ramli; El Mokhtar Essassi; Mohamed Saadi; Lahcen El Ammari
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2014-08-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.